Based on HCA’s trading price on Oct. 29, Bain Capital and KKR will net $1.42 billion from the sale. The offering is expected to close Friday. HCA also agreed to repurchase an additional $500 million of shares from Bain Capital and KKR.
Bain Capital and KKR are two of the major private equity investors of HCA. This is now the third major stock offering for the firms in the past year. In February, they sold 50 million shares of HCA stock for about $1.8 billion, and in December, a sale of 32 million shares netted more than $1 billion. Cumulatively, the three deals will result in approximately $4.3 billion.
More Articles on HCA:
For-Profit Hospital Stock Report: Week of Oct. 21-25, 2013
HCA Names Glenn Wallace CEO of New $71M Hospital in Texas
HCA: Q3 Profits, Admissions Looking Positive
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
